Implantable glucose sensors for diabetes monitoring

References

• The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–86.
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study Group. Intensive blood- glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–53.
   Google Scholar
• Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose: independent risk factor for long term prognosis after myocardial infarction even in nondia- betic patients. Diabetes Care 1999;22:1827–31.
   PubMed Web of Science ®Google Scholar
• Zindrou D, Taylor KM, Bagger JP. Admission plasma glucose: an independent risk factor in nondiabetic women after coronary artery bypass grafting. Diabetes Care 2001;24:1634–9.
   Google Scholar
• Van den Berghe G, Wouters P, Weekers F, Verwaest C et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359–67.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Bedside blood glu- cose monitoring in hospitals. Diabetes Care 2003; 26 (Suppl. 1): S119.
   Google Scholar
• Renard E. Insulin therapy by insulin pump: continuous or conventional self-blood glucose monitoring? Dia- betes Metab 2003;29:2S54–62.
   Google Scholar
• Jaremko J, Rorstad O. Advances toward the implan- table artifcial pancreas for treatment of diabetes. Diabetes Care 1998;21:444–50.
   PubMed Web of Science ®Google Scholar
• Gough D, Armour JC. Development of the implantable glucose sensor: what are the prospects and why is it taking so long? Diabetes 1995;44:1005–9.
   PubMedGoogle Scholar
• Caduff A, Buschor S, Dewarrat R, Schrepfer T et al. Evaluation of a non-invasive, continuous glucose moni- toring system in patients with diabetes: results of a glucose clamp study with hypoglycemic and hyper- glycemic excursions. Diabetologia 2003; 46(Suppl. 2): A45, 121.
   Google Scholar
• Renard E. Implantable closed loop glucose-sensing and insulin delivery: the future for insulin pump therapy. Curr Opin Pharmacol 2003;2:708–16.
   Google Scholar
• Fischer U. Fundamentals of glucose sensors. Diabet Med 1991;8:309–21.
   Google Scholar
• Gough DA, Armour JC, Baker DA. Advances and prospects in glucose assay technology. Diabetologia 1997;40 (Suppl. 2): S102–7.
   Google Scholar
• Kulcu E, Tamada JA, Reach G, Potts RO et al. Physio- logical differences between interstitial glucose and blood glucose measured in human subjects. Diabetes Care 2003;26:2405–9.
   PubMed Web of Science ®Google Scholar
• Ward WK, Jansen LB, Anderson E, Reach G et al. A new amperometric glucose microsensor: in vitro and short-term in vivo evaluation. Biosens Bioelectron 2002;17:181–9.
   PubMed Web of Science ®Google Scholar
• Garg SK, Potts RO, Ackerman NR, Fermi SJ et al. Correlation of fngerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes. Diabetes Care 1999;22:1708–14.
   PubMed Web of Science ®Google Scholar
• Potts RO, Tamada JA, Tierney MJ. Glucose monitoring by reverse iontophoresis. Diabetes Metab Res Rev 2002;18 (Suppl. 1): S49–53.
   Google Scholar
• Pitzer KR, Desai S, Dunn T, Edelman S et al. Detection of hypoglycemia with the GlucoWatch Biographer. Diabetes Care 2001;24:881–5.
   PubMed Web of Science ®Google Scholar
• Mastrototaro JJ. The MiniMed Continuous Glucose Monitoring System. Diabetes Technol Ther 2000; 2 (Suppl. 1): S13–18.
   Google Scholar
• Rebrin K, Steil GM, Van Antwerp WP, Mastrototaro JJ. Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. Am J Physiol 1999;277 (Endocrinol Metab 40): E561–71.
   Google Scholar
• Cheyne E, Kerr D. Making ‘sense’ of diabetes: using a continuous glucose sensor in clinical practice. Dia- betes Metab Res Rev 2002;18 (Suppl. 1): S43–8.
   Google Scholar
• Melki V, Hanaire-Broutin H. Indication of CGMS (Continuous Glucose Monitoring System) in the func- tional investigations of adult type 1 diabetic patients. Diabetes Metab 2001;27:618–23.
   Google Scholar
• Boyne MS, Silver DM, Kaplan J, Saudek CD. Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes 2003;52:2790–4.
   PubMed Web of Science ®Google Scholar
• Metzger M, Leibowitz G, Wainstein J, Glaser B et al. Reproducibility of glucose measurements using the glucose sensor. Diabetes Care 2002;25:1185–91.
   PubMed Web of Science ®Google Scholar
• Monsod TP, Flanagan DE, Rife F, Saenz R et al. Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia. Diabetes Care 2002;25:889–93.
   PubMed Web of Science ®Google Scholar
• Guerci B, Floriot M, Bo” hme P, Durain D et al. Clinical performance of CGMS in type 1 diabetic patients treated by continuous insulin infusion using insulin analogs. Diabetes Care 2003;26:582–9.
   PubMed Web of Science ®Google Scholar
• Heinemann L, Koschinsky T. Continuous glucose monitoring: an overview of today’s technologies and their clinical applications. Int J Clin Pract 2002;Suppl: 75–9.
   Google Scholar
• Bode BW, Gross TM, Thornton KR, Mastrototaro JJ. Continuous glucose monitoring used to adjust dia- betes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract 1999;46:183–90.
   PubMed Web of Science ®Google Scholar
• Kaufman FR, Gibson LC, Halvorson M, Carpenter S et al. A pilot study of the continuous glucose monitoring system. Clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care 2001;24:2030–4.
   Web of Science ®Google Scholar
• Chico A, Vidal-Rios P, Subira M, Novials A. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improv- ing metabolic control. Diabetes Care 2003;26:1153–7.
   PubMed Web of Science ®Google Scholar
• Desouza C, Salazar H, Cheong B, Murgo J et al. Association of hypoglycemia and cardiac ischemia. A study based on continuous monitoring. Diabetes Care 2003;26:1485–9.
   PubMed Web of Science ®Google Scholar
• Kerner W. Implantable glucose sensors: present status and future developments. Exp Clin Endocrinol Dia- betes 2001;109 (Suppl. 2): S341–6.
   Google Scholar
• Meyerhoff C, Bischof F, Sternberg F, Zier H et al. On line continuous monitoring of subcutaneous tissue glucose in men by combining portable glucosensor with microdialysis. Diabetologia 1992;35:1087–92.
   PubMedGoogle Scholar
• Bolinder J, Hagstrom-Toft E, Ungerstedt U, Arner P. Self-monitoring of blood glucose in type 1 diabetic patients: comparison with continuous microdialysis measurements of glucose in subcutaneous adipose tissue during ordinary life conditions. Diabetes Care 1997;20:64–70.
   Google Scholar
• Maran A, Crepaldi C, Tiengo A, Grassi G et al. Con- tinuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care 2002;25:347–52.
   PubMed Web of Science ®Google Scholar
• Wientjes KJ, Schoonen AJ. Determination of time delay between blood and interstitial adipose tissue glucose concentration change by microdialysis in healthy volunteers. Int J Artif Organs 2001;24:884–9.
   Google Scholar
• Freckmann G, Kalatz B, Pfeiffer B, Hoss U et al. Recent advances in continuous glucose monitoring. Exp Clin Endocrinol Diabetes 2001;109 (Suppl. 2): S347–57.
   Google Scholar
• Beyer U, Schafer D, Thomas A, Aulich H et al. Recording of subcutaneous glucose dynamics by a viscometric affnity sensor. Diabetologia 2001;44:416–23.
   Google Scholar
• Updike SJ, Shults MC, Gilligan BJ, Rhodes RK. A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration. Diabetes Care 2000;23:208–14.
   PubMed Web of Science ®Google Scholar
• Armour JC, Lucisano JY, McKean BD, Gough DA. Application of chronic intravascular glucose sensor in dogs. Diabetes 1990;39:1519–26.
   PubMed Web of Science ®Google Scholar
• Edelman SV, Bouvet M, Fisher JC, Cefalu W. Glucose sensor in the subcutaneous tissue: continuous data in patients with type 1 diabetes. Diabetes 2002; 51 (Suppl. 2): A12,48-OR.
   Google Scholar
• Renard E, Costalat G, Bringer J. From external to implantable insulin pump, can we close the loop? Diabetes Metab 2002; 28 (2 Pt 2): 2S19–25.
   Google Scholar
• Renard EM, Shah R, Miller M, Kolopp M et al. Sustained safety and accuracy of central IV glucose sensors connected to implanted insulin pumps and short-term closed-loop trials in diabetic patients. Diabetologia 2003;46 (Suppl. 2): A47,128.
   Google Scholar
• Bode BW. Clinical utility of the Continuous Glucose Monitoring System. Diabetes Technol Ther 2000; 2 (Suppl. 1): S35–41.
   Google Scholar
• McGowan K, Thomas W, Moran A. Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care 2002;25:1499–503.
   PubMed Web of Science ®Google Scholar
• Choleau C, Dokladal P, Klein JC, Ward WK et al. Prevention of hypoglycemia using risk assessment with a continuous glucose monitoring system. Diabetes 2002;51:3263–73.
   Google Scholar